2026 International Congress » Huntington's Disease

Anticipatory Language Prediction ERPs Detect Early Neurophysiological Changes in Asymptomatic Huntington’s Disease

A. Puig-Davi, L. Perez-Carasol, C. Franch-Marti, J. Perez-Perez, G. Olmedo-Saura, J. Rodriguez-Antiguedad, L. Bojtos, I. Ruiz-Barrio, J. Pagonabarraga, J. Kulisevsky, S. Martinez-Horta (Barcelona, Spain)

Antidepressants in Huntington’s Disease: A Meta Analysis of Mood and Motor Outcomes with Placebo-controlled Trials

J. Patino, J. Pitton Rissardo, A. Fornari Caprara, A. Mcgarry, I. Walker, N. Rocha, A. Duker, E. Furr Stimming (Camden, USA)

Clinical and Phenotypic Features of Concurrent Huntington’s Disease and Amyotrophic Lateral Sclerosis: A Case Series

J. Mitzner, D. Lacomis, V. Suski (Pittsburgh, USA)

Clinical Profile and Key Correlates of Genetic Load, Motor Severity, and Caregiver Burden in an Iranian Huntington’s Disease Cohort

M. Salari, K. Rezaei, M. Etemadifar (Tehran, Islamic Republic of Iran)

Depressive Symptoms and Functional Impairment in Huntington’s Disease A Brazilian Cohort Study

D. Corrêa, D. Maia, R. Maciel, F. Cardoso (Belo Horizonte, Brazil)

Early Reduction in Cerebral Histamine 3 Receptor Expression in People with Huntington’s Disease: Results from the iMarkHD Study

D. van Wamelen, M. Moretto, J. Badenoch, A. Calvano, P. Eze, M. Hartmann, Z. Kovkasyuk, C. Madrigal-Esquivel, O. Makos, N. Martin, A. Rangel-Cristales, J. Staunton, P. Tall, N. Palasits, A. Wood, F. Turkheimer, M. Veronese, S. Williams (London, United Kingdom)

Effectiveness and Safety of Deutetrabenazine in Chinese Patients with Huntington’s Disease-associated Chorea: A Multicenter Phase 4 Study

Y. Cheng, Y. Huang, J. Ma, J. Yin, X. Dan, J. Qu, Y. Li, G. Zhang, KT. Ustundag, AP. Levin, R. Ribalov, H. Xie, R. Eshet, M. Zeygarnik, J. Wang, H. Shang (Chengdu, China)

Efficacy and Adverse Events of Tetrabenazine, Deutetrabenazine, and Valbenazine in Huntington’s Disease

J. Patino, J. Pitton Rissardo, A. Fornari Caprara, A. Mcgarry, I. Walker, N. Rocha, A. Duker, E. Furr Stimming (Cincinnati, USA)

Efficacy of Rapid-Succession “Flash Song” Music Therapy on Cognitive and Behavioral Symptoms in Outpatients with Juvenile Huntington’s Disease

A. Gangadhar, Y. Dayma (Pune, India)

Exploring the Relationship Between Circadian Disruption, Depression and Suicidal Ideation in People with Huntington’s Disease (Mind & Clock Study)

A. Rangel Cristales, A. Hampshire, D. van Wamelen (London, United Kingdom)

Extracellular Small RNAs in Huntington’s disease: from Brain to CSF Analysis

G. Olmedo-Saura, M. Herrero-Lorenzo, A. Cardona-Collado, A. Puig-Davi, A. Vazquez-Oliver, E. Rivas-Asensio, D. Alcolea, C. Franch-Marti, S. Martinez-Horta, A. Gámez-Valero, J. Kulisevsky, J. Perez Perez, E. Martí (Barcelona, Spain)

FuRST 2.0, A Patient Reported Outcome (PRO) Measure of Functional Ability in Huntington’s Disease (HD): Getting Response Options Right

R. Fuller, M. Roche, N. Sinha, S. Sathe, C. Sampaio, G. Stebbins (Princeton, USA)

HD-RAC (Huntington’s Disease Research at Convention) Series: Novel approach to pilot data collection for outcome measures in Huntington’s disease

S. Sathe, M. Roche, R. Fuller, G. Phelan, C. Harwood, S. Lacy, S. Lazic, S. Smith, H. Wilkinson, C. Sampaio (Princeton, USA)

Huntington’s Disease Genetic Testing Practices in the Lower North Island of New Zealand

D. Llewelyn, D. Bourke (Wellington, New Zealand)

Intrinsic Suppression of the NRF2–Ferroptosis Defense Axis Defines Selective Vulnerability of D2-Striosome Neurons in Huntington’s Disease

LY. Lu, ZQ. Chen, Y. Huang (Beijing, China)

Late-Onset Huntington’s Disease Misdiagnosed as Post-Stroke Chorea: A Case Report

JSL. Lee, SY. You (Daegu, Republic of Korea)

Multi-tracer positron emission tomography reveals early disruption of cerebrospinal fluid clearance in Huntington’s disease

A. Calvano, F. Turkheimer, M. Veronese, M. Moretto, H. Tang, A. Wood, S. Williams, D. van Wamelen, J. Schubert (London, United Kingdom)

Non-motor symptoms in Huntington’s disease: Results from the Validation of the Non-motor Symptoms Scale (MDS-NMS)

J. Valera-Bermejo, O. Makos, P. Eze, D. van Wamelen (London, United Kingdom)

Patient and Caregiver Perspectives on Patient Burden of Huntington Disease Chorea and the Real‑World Impact of Deutetrabenazine Treatment

D. Claassen, W A. Dalrymple, P. Gandhi, D. Klakotskaia, M. Konings, H. Moore, K. Anderson (Nashville, USA)

Perception of Early-Intervention Therapies and Clinically Meaningful Delays in Huntington’s Disease Onset and Progression: The Pre-HDBOI Study

A. Toumadj, I. Rodriguez-Santana, C. Mighiu, A. Arnesen, B. Balas (Lexington, USA)

PET Imaging of Presynaptic Terminals with [18F]SynVesT-1 in Premanifest Huntington’s Disease

J. van Opstal, G. Vanderlinden, A. Delva, K. van Laere, W. Vandenberghe (Leuven, Belgium)

PPAR-γ-dependent Neuroprotection by Ferulic acid improves Motor deficits in 3-nitropropionic acid model of Huntington’s disease in rats

N. Singh, V. Singh (bathinda, India)

Processing Speed across Huntington’s Disease Stages and its association with Striatal PDE10A Density

C. Madrigal Esquivel, A. Rangel Cristales, A. Wood, F. Turkheimer, J. Badenoch, J. Valera Bermejo, J. Staunton, M. Moretto, M. Veronese, M. Hartmann, N. Martin, N. Palasits, O. Makos, P. Eze, P. Tall, S. Williams, D. van Wamelen (London, United Kingdom)

Psychiatric manifestations in premanifest Huntington’s disease as early indicators of motor onset: a systematic review

E. Pérez Rodríguez, R. Cundapí González, I. González López, K. Gálvez Deleón, S. Domínguez Castro, D. Velázquez Ruiz, M. Serrano Velázquez, O. Barrios Julian (Tapachula, Mexico)

Psychiatric Symptoms and Quality of Life in Huntington’s Disease Evidence from a Brazilian Cohort

D. Corrêa, D. Maia, R. Maciel, F. Cardoso (Belo Horizonte, Brazil)

Psychotic Symptoms and Cognitive Impairment in Huntington’s Disease

D. Corrêa, D. Maia, R. Maciel, F. Cardoso (Belo Horizonte, Brazil)

Real-World Evaluation of Deutetrabenazine for Huntington Disease–Associated Chorea in South Korea: Study Design and Baseline Characteristics

M. Jung, R. Eshet, K. Tuğrul üstündağ, A. Peyser Levin (Seoul, Republic of Korea)

Sleep Architecture and Cognitive Performance in Early Huntington’s Disease: A Pilot Study

E. Forbes, L. Lattanzio, D. Carter, A. Amara (Aurora, USA)

Sleep Disturbances in Huntington’s Disease A Cross-Sectional Study

G. Hemicker, A. Stefani, B. Heim, E. Hametner, B. Frauscher, A. Djamshidian, F. Krismer, B. Högl, K. Seppi (Innsbruck, Austria)

Speech Changes as Biomarkers in Huntington’s Disease: a Meta-Analysis

D. Nguyen, S. Yan, M. Elias, Y. Altun (Bronx, USA)

Stimulation-Level Sweet-Spot and Connectivity Analysis of Pallidal DBS in Huntington’s Disease

M. Borrell-Pichot, G. Olmedo-Saura, A. Puig-Davi, C. Franch-Marti, S. Martínez-Horta, R. Rodríguez-Rodríguez, JA. Aibar-Duran, R. Martínez-Fernández, B. Pascual-Sedano, J. Kulisevsky, J. Pérez-Pérez, I. Aracil-Bolaños (Barcelona, Spain)

Strategies for Participant Retainment in Large Observational Studies in Movement Disorders: a Single Centre Experience

M. Hartmann, A. Rangel Cristales, C. Madrigal Esquivel, N. Martin, O. Makos, J. Staunton, P. Tall, D. van Wamelen (London, United Kingdom)

Suicidal Ideation and the Hippocampal Histaminergic System in Huntington’s Disease: A PET Study

P. Eze, C. Madrigal-Esquivel, O. Makos, A. Rangel-Cristales, J. Valera-Bermejo, M. Moretto, N. Martin, P. Tall, J. Staunton, M. Hartmann, F. Turkheimer, J. Badenoch, M. Veronese, N. Palasits, A. Wood, S. Williams, D. van Wamelen (London, United Kingdom)